Business Context and Reporting Period
This Form 8-K was filed by Medtronic Plc on February 17, 2015. The filing serves as a Regulation FD disclosure to announce the third quarter 2015 financial results of Medtronic, Inc. The report clarifies that the results for Medtronic Plc for the quarter ended January 23, 2015, are not material as this period precedes the closing of the acquisition of Covidien plc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document states that the detailed financial results are contained in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The primary material change noted is the pending integration of Covidien plc. The filing specifies that the first reporting period to include the combined results of operations for Medtronic, Inc. and Covidien plc as subsidiaries of Medtronic Plc will be the period ending April 24, 2015.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, or risk factors within the text provided. It references a press release for the announcement of the third quarter 2015 results but does not summarize the content of that release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific third quarter 2015 financial figures for Medtronic, Inc.
- Confirm the closing date of the Covidien plc acquisition to understand the start of consolidated reporting.
- Monitor the next quarterly report (ending April 24, 2015) for the first combined financial results of Medtronic and Covidien.